Preventive Maintenance, Service, Support, and Coverage for (1) Government-Owned AutoGen GENEPREP with Stacker - automated DNA isolation machine
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Cancer Institute (NCI) intends to award a sole source purchase order to Autogen Inc. for preventive maintenance, service, support, and coverage for a Government-owned AutoGen GENEPREP with Stacker automated DNA isolation machine. This is a notice of intent, not a request for competitive proposals. Interested parties may submit a statement of capabilities by March 19, 2026, to challenge the sole source determination.
Scope of Work
The requirement is for annual preventive service maintenance for the GENEPREP w/ Stacker instrument (S/N 481102/825056), which is used daily by the NCI's Experimental Immunology Branch (EIB). Services include all labor, material, and equipment for maintenance, performed in accordance with the manufacturer's standard practices.
Contract & Timeline
- Action Type: Notice of Intent to Award Sole Source (under FAR Subpart 13.106-1(b))
- Intended Awardee: Autogen Inc., 84 October Hill Road, Holliston, MA 01746-1371
- Period of Performance: March 23, 2026, through March 22, 2027
- NAICS Code: 811210 – Electronic and Precision Equipment Repair and Maintenance (Size Standard: $34M)
- Set-Aside: Not applicable (Sole Source Intent)
- Response Due: March 19, 2026
- Published: March 13, 2026
- Place of Performance: Bethesda, MD 20892, United States
Evaluation
NCI intends to negotiate directly with Autogen Inc. and will not issue a solicitation. Responses from interested parties will be considered to determine if a competitive procurement is feasible. A determination not to compete is at the Government's discretion. Award is subject to approval of the Sole Source Justification.
Additional Notes
This procurement will be processed using Simplified Acquisition Procedures. There is no solicitation package available. For questions, contact Rita Davis via email at rita.davis@hhs.gov.